Sartorius Stedim Biotech (LTS:0RG8) FFO


LTS:0RG8 Sartorius Stedim Biotech SA LTS:0RG8
84 GF Score
Price €178.35
GF Value €203.63
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sartorius Stedim Biotech FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0RG8
84GF Score
Sartorius Stedim Biotech SA LTS:0RG8
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sartorius Stedim Biotech (LTS:0RG8) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued. The current stock price of €178.35 is trading 12.4% below its estimated GF Value™ of €203.63. GuruFocus considers Sartorius Stedim Biotech to be Modestly Undervalued.

Key valuation signals for LTS:0RG8:

  • FFO:
  • GF Value™: €203.63 vs. price of €178.35 (12.4% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the LTS:0RG8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sartorius Stedim Biotech Business Description

Address Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
84GF Score

Get the complete analysis for LTS:0RG8

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€178.35
Price
€203.63
GF Value